## Abstract The results obtained by liver transplantation (TX) (n = 105) for hepatocellular carcinoma (HCC) were compared with those achieved by hepatic resection (HX) (n = 76). Overall 1β to 5βyear survival rates after TX were 66%, 49%, 39%, 36%, and 36%, and those after HX were 71%, 55%, 47%, 37%
Liver transplantation in the treatment of hepatocellular carcinoma
β Scribed by Marsh, J. Wallis ;Dvorchik, Igor ;Iwatsuki, Shunzaburo
- Publisher
- Springer
- Year
- 1998
- Tongue
- English
- Weight
- 115 KB
- Volume
- 5
- Category
- Article
- ISSN
- 0944-1166
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Hepatocellular carcinoma (HCC) is a relatively common cancer and occurs mainly in patients with liver cirrhosis (85%-95%). A significant number of cases are, however, diagnosed in normal and noncirrhotic/nonfibrotic livers. In contrast to HCC in a cirrhotic liver, noncirrhotic hepatocellular carcino
Several retrospective analyses have recently shown the advantage of liver transplantation (OLT) for patients with hepatocellular carcinoma (HCC) at early tumor stages. Preliminary results of a prospective series of OLT for unresectable small HCC arising in cirrhosis are reported. Eighteen out of 22